iKala
Last funding round
Raised
$20,800,000
Round
Series B
Startup details
iKala is a leading AI transformation solutions provider, offering AI-driven cloud services and marketing technology to enterprises, including Fortune 500 firms. The company's AI influencer platform, KOL Radar, has over three million global influencers and has expanded to markets like Japan, Hong Kong, and Southeast Asia.
Investment details
Total Funding
$50,000,000
Founder Stories
Dr. Sterghois Moschos, PulmoBioMed
Recent 5 from AI
Jul2024
1
3 weeks ago
Trondheim-based Versiro uses AI to aid power producers in real-time market decisions.
Founders
Simon Risanger
In News
EU-Startups
2
3 weeks ago
London-based Gendo transforms 2D sketches into realistic visualizations for architects and designers.
Founders
George Proud
In News
Tech Funding News
3
3 weeks ago
Melbourne-based Redactive AI provides a developer platform addressing AI engineering and security skill gaps in enterprise software teams.
Founders
Alexander Valente,
Andrew Pankevicius,
Lucas Sargent
In News
FinSMEs
SiliconANGLE
SmartCompany
Business News Australia
4
3 weeks ago
Open-source AI platform Sentient with Polygon co-founder as core contributor, raised $85M in seed funding. Competing with OpenAI.
Founders
Himanshu Tyagi
In News
The Block
Coindesk
5
3 weeks ago
Atlanta-based Prodia is a distributed GPU cloud for AI inference, reducing costs and accelerating generation speeds.
Founders
Monty Anderson,
Mikhail Avady
In News
PR Newswire
Recent 5 from Taiwan
Jul2024
1
4 weeks ago
Taiwan-based Cooby integrates WhatsApp with CRM systems to streamline sales workflows.
Founders
Wen Shaw
In News
GlobeNewswire News Room
2
1 month ago
Taipei-based XREX is a blockchain-enabled financial institution offering enterprise-grade banking services to SMBs in emerging markets and novice-friendly financial services globally.
Founders
Wayne Huang,
Winston Hsiao
In News
PR Newswire
3
5 months ago
Taiwan-based H2U promotes Lifestyle Medicine through AI-driven precision nutrition and holistic health solutions.
Founders
SAXON CHEN
In News
Macau Business
PR Newswire
4
5 months ago
Taipei-based Anbogen Therapeutics is a clinical-stage biotechnology company developing precision anti-cancer drugs.
Founders
TsungKai (Angus) Wu
In News
FinSMEs
PR Newswire